Some women with breast cancer are calling it quits with their aromatase inhibitor
June 2007
Some women with breast cancer are calling it quits with their aromatase inhibitor...Arimidex, Aromasin, and Femara.
Aromatase inhibitors work better than tamoxifen to prevent recurrence of estrogen-receptor positive breast cancer in postmenopausal women.
And they were initially thought to be better tolerated.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote